Vertex Pharmaceuticals (Australia) Pty Ltd Level 32, 101 Miller Street North Sydney NSW[removed]Media Alert

First Page		Document Content
Date: 2014-11-30 16:49:26 Phenols Quinolones Pancreas disorders Biology Cystic fibrosis Vertex Pharmaceuticals Genetics VX-809 Health Anilides Ivacaftor		Vertex Pharmaceuticals (Australia) Pty Ltd Level 32, 101 Miller Street North Sydney NSW[removed]Media Alert Add to Reading List Source URL: www.cysticfibrosis.org.au Download Document from Source Website File Size: 189,09 KB Share Document on Facebook

	Microsoft Word - Document1 DocID: 14AfY - View Document
	6.11 IVACAFTOR Tablet; 150 mg; Kalydeco®; Vertex Pharmaceuticals (Australia) Pty Ltd. Purpose of Application DocID: 12pOE - View Document
	MEDIA RELEASE 26 June 2014 For immediate release Positive results from latest clinical trial combining Kalydeco and new drug lumacaftor in people with most common from of cystic fibrosis DocID: XHE7 - View Document
	Microsoft Word - Document1 DocID: XkHP - View Document
	Vertex Pharmaceuticals (Australia) Pty Ltd Level 32, 101 Miller Street North Sydney NSW[removed]Media Alert DocID: WWZF - View Document